Curis | CRIS - Current Assets


Curis reported $6.92M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
CSL USD 11.85B 1000K Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Eli Lilly USD 54.84B 794M Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Incyte USD 5.48B 460.36M Mar/2026
Merck USD 35.02B 8.5B Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Takeda JPY 3.09T 25.94B Mar/2026
TG Therapeutics USD 1.09B 456.2M Mar/2026
Verastem USD 223.41M 69.36M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025